Key result
Baseline evaluation of 357 ACS patients showed that 79.6% received guideline-directed discharge medications, but only 22.3% of those with prior CAD achieved optimal LDL-C <70 mg/dl at admission.
Why the study?
Given the rising burden of cardiovascular risk factors and advances in ACS management, epidemiological characteristics, treatment strategies, lipid profiles, and lipid goal attainment needed evaluation in a real-world setting.
RCT (n=357)
No
Despite high rates of guideline-directed medical therapy prescription at discharge, secondary prevention lipid goals are largely unachieved in patients presenting with ACS.
No takes yet. Share an insight, caveat, or question.
Persistent LDL-C target failure in CAD patients at ACS admission despite statins; leaves open barriers and intensification strategies.
Farmakis et al. (2019) conducted an RCT in Acute coronary syndrome (n=357). Motivational interviewing was evaluated on Epidemiological characteristics, treatment strategies, and lipid profile. Baseline evaluation of 357 ACS patients showed that 79.6% received guideline-directed discharge medications, but only 22.3% of those with prior CAD achieved optimal LDL-C <70 mg/dl at admission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: